NCT03072069

Brief Summary

Anesthesia in the modern age is at least a two-drug process consisting of an opioid and a sedative hypnotic (e.g., fentanyl and propofol in combination, among others). Therefore, it is important to understand the interaction pharmacodynamics of these agents as they are used clinically. A good method for visualizing the pharmacodynamic interaction behavior of drug combinations is through response surface models. Unlike traditional isobolograms that represent the concentrations of two agents that combine to produce a single degree of drug effect, response surface models characterize the complete spectrum of interaction between two or more agents for all possible levels of concentration and effect. The investigators try to use the response surface model to evaluate the effect of anesthetic combination of autonomic system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

February 21, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 7, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2018

Completed
Last Updated

February 28, 2019

Status Verified

February 1, 2019

Enrollment Period

1 year

First QC Date

February 21, 2017

Last Update Submit

February 27, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • change of heart rate variability

    propofol anesthesia or combination with other anesthetics would affect HRV depending on the concentrations

    up to 24 weeks

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

A prospective, observational, non-randomized study was conducted in 30 patients with American Society of Anaesthesiologists (ASA) physical status I who underwent elective surgery. Participants ages ranged from 20 to 60 years. Exclusion criteria were recent administration of sedative or opioid drugs, emergency surgery and impairment of renal, hepatic, cardiac or respiratory function. No sedative or opioid drugs were administered before induction of anaesthesia.

You may qualify if:

  • American Society of Anaesthesiologists (ASA) physical status I who underwent elective surgery.

You may not qualify if:

  • recent administration of sedative or opioid drugs, emergency surgery and impairment of renal, hepatic, cardiac or respiratory function. No sedative or opioid drugs were administered before induction of anaesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, Hsin-chu Branch, Taipei Veterans General Hospital, Taiwan

Hsinchu, 320, Taiwan

Location

Study Officials

  • Chien-Kun Ting, PhD

    National Yang Ming Chiao Tung University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 21, 2017

First Posted

March 7, 2017

Study Start

February 21, 2017

Primary Completion

February 21, 2018

Study Completion

February 21, 2018

Last Updated

February 28, 2019

Record last verified: 2019-02

Locations